by Team Small News | Jan 2, 2026 | Dr Reddy's
Dr. Reddy’s Laboratories has faced a setback in its efforts to bring its denosumab biosimilar, AVT03, to the US market. The US Food and Drug Administration (USFDA) has issued a warning letter to the company after conducting an inspection of its manufacturing...
by Team Small News | Dec 31, 2025 | Dr Reddy's
The Vizag Pharma Summit 2025 is scheduled to take place on December 17th, 2025, at the Fairfield by Marriott in Vizag. The event will feature a speaker, Mr. Gurupyar Reddy, who is the Head of Production Complex Injections at Dr. Reddy’s Laboratories. Mr. Reddy...
by Team Small News | Dec 30, 2025 | Dr Reddy's
The Delhi High Court has issued a restraining order against Dr. Reddy’s Laboratories, preventing the company from using the ‘SUN’ mark on their sunscreen product labels. This decision comes after a lawsuit was filed by Sun Pharmaceutical Industries,...
by Team Small News | Dec 27, 2025 | Dr Reddy's
An error occurred during the execution of a web request, resulting in an unhandled exception. The exception was a System.FormatException, which indicates that the input string was not in the correct format. This error occurred in the Page_Load method of the...
by Team Small News | Dec 25, 2025 | Dr Reddy's
A new sign has been erected at the former Dr. Reddy’s plant in Shreveport, indicating that Frymaster, a commercial fryer manufacturer, will be occupying the space. This development marks a significant turning point for the facility, which was previously home to...
by Team Small News | Dec 14, 2025 | Dr Reddy's
The US Food and Drug Administration (FDA) has approved two new oral medicines, Nuzolvence (zoliflodacin) and Blujepa (gepotidacin), to treat gonorrhea, a common sexually transmitted infection (STI) that is increasingly resistant to existing treatments. The World...